{"version":"1.0","type":"link","title":"T-Cell-Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions.","author_name":"Caserta S 외","author_url":"https://prs-insight.online/author/Caserta%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/85806","thumbnail_width":1200,"thumbnail_height":630}